231 related articles for article (PubMed ID: 24568298)
1. Binding modes of chain arylpiperazines to 5-HT1a, 5-HT2a and 5-HT7 receptors.
Bielenica A; Kozioł AE; Struga M
Mini Rev Med Chem; 2013 Aug; 13(10):1516-39. PubMed ID: 24568298
[TBL] [Abstract][Full Text] [Related]
2. Computational methods in determination of pharmacophore models of 5-HT(1A), 5-HT(2A) and 5-HT(7) receptors.
Bielenica A; Kozioł AE; Struga M
Mini Rev Med Chem; 2013 Jun; 13(7):933-51. PubMed ID: 23544602
[TBL] [Abstract][Full Text] [Related]
3. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors.
Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K
Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907
[TBL] [Abstract][Full Text] [Related]
4. Recognition of repulsive and attractive regions of selected serotonin receptor binding site using FMO-EDA approach.
Śliwa P; Kurczab R; Kafel R; Drabczyk A; Jaśkowska J
J Mol Model; 2019 Apr; 25(5):114. PubMed ID: 30955095
[TBL] [Abstract][Full Text] [Related]
5. Effects of 5-HT
Fletcher PJ; Zeeb FD; Browne CJ; Higgins GA; Soko AD
Psychopharmacology (Berl); 2017 Mar; 234(5):889-902. PubMed ID: 28097374
[TBL] [Abstract][Full Text] [Related]
6. 5-HT
Ostrowska K; Grzeszczuk D; Głuch-Lutwin M; Gryboś A; Siwek A; Leśniak A; Sacharczuk M; Trzaskowski B
Bioorg Med Chem; 2018 Jan; 26(2):527-535. PubMed ID: 29269256
[TBL] [Abstract][Full Text] [Related]
7. Homology modeling of the human 5-HT1A, 5-HT 2A, D1, and D2 receptors: model refinement with molecular dynamics simulations and docking evaluation.
Yap BK; Buckle MJ; Doughty SW
J Mol Model; 2012 Aug; 18(8):3639-55. PubMed ID: 22354276
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and 5-HT1A/5-HT2A receptor activity of N-(4-arylpiperazin-1-yl)alkyl derivatives of 2-azaspiro([4.4]nonane and [4.5]decane-1,3-dione.
Obniska J; Tatarczyńska E; Nikiforuk A; Charakchieva-Minol S; Duszyńska B
Pharmacol Rep; 2006; 58(1):107-14. PubMed ID: 16531637
[TBL] [Abstract][Full Text] [Related]
9. The impact of the halogen bonding on D
Partyka A; Kurczab R; Canale V; Satała G; Marciniec K; Pasierb A; Jastrzębska-Więsek M; Pawłowski M; Wesołowska A; Bojarski AJ; Zajdel P
Bioorg Med Chem; 2017 Jul; 25(14):3638-3648. PubMed ID: 28529043
[TBL] [Abstract][Full Text] [Related]
10. New pyridobenzoxazepine derivatives derived from 5-(4-methylpiperazin-1-yl)-8-chloro-pyrido[2,3-b][1,5]benzoxazepine (JL13): chemical synthesis and pharmacological evaluation.
Liégeois JF; Deville M; Dilly S; Lamy C; Mangin F; Résimont M; Tarazi FI
J Med Chem; 2012 Feb; 55(4):1572-82. PubMed ID: 22268448
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, biological evaluation, and docking studies of tetrahydrofuran- cyclopentanone- and cyclopentanol-based ligands acting at adrenergic α₁- and serotonine 5-HT1A receptors.
Prandi A; Franchini S; Manasieva LI; Fossa P; Cichero E; Marucci G; Buccioni M; Cilia A; Pirona L; Brasili L
J Med Chem; 2012 Jan; 55(1):23-36. PubMed ID: 22145629
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles.
Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H
Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766
[TBL] [Abstract][Full Text] [Related]
13. Interaction of the novel antipsychotic aripiprazole with 5-HT1A and 5-HT 2A receptors: functional receptor-binding and in vivo electrophysiological studies.
Stark AD; Jordan S; Allers KA; Bertekap RL; Chen R; Mistry Kannan T; Molski TF; Yocca FD; Sharp T; Kikuchi T; Burris KD
Psychopharmacology (Berl); 2007 Feb; 190(3):373-82. PubMed ID: 17242925
[TBL] [Abstract][Full Text] [Related]
14. Introduction of a new complex imide system into the structure of LCAPs. The synthesis and a 5-HT1A, 5-HT2A and D2 receptor binding study.
Kossakowski J; Raszkiewicz A; Bugno R; Bojarski AJ
Pol J Pharmacol; 2004; 56(6):843-8. PubMed ID: 15662099
[TBL] [Abstract][Full Text] [Related]
15. Serotonin modifies the spontaneous spiking activity of gracile nucleus neurons in rats: role of 5-HT1A and 5-HT2 receptors.
Grasso C; Li Volsi G; Barresi M
Arch Ital Biol; 2016 Jun; 154(2-3):39-49. PubMed ID: 27918061
[TBL] [Abstract][Full Text] [Related]
16. Overcoming Depression with 5-HT
Zięba A; Stępnicki P; Matosiuk D; Kaczor AA
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008436
[TBL] [Abstract][Full Text] [Related]
17. Novel 4-alkyl-1-arylpiperazines and 1,2,3,4-tetrahydroisoquinolines containing diphenylmethylamino or diphenylmethoxy fragment with differentiated 5-HT1A/5-HT2A/D2 receptor activity.
Paluchowska MH; Mokrosz MJ; Charakchieva-Minol S; Duszyńska B; Kozioł A; Wesołowska A; Stachowicz K; Chojnacka-Wójcik E
Pol J Pharmacol; 2003; 55(4):543-52. PubMed ID: 14581712
[TBL] [Abstract][Full Text] [Related]
18. Structure-5-HT receptor affinity relationship in a new group of 7-arylpiperazynylalkyl and 7-tetrahydroisoquinolinylalkyl derivatives of 8-amino-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione.
Żmudzki P; Chłoń-Rzepa G; Bojarski AJ; Zygmunt M; Kazek G; Mordyl B; Pawłowski M
Arch Pharm (Weinheim); 2015 Apr; 348(4):229-41. PubMed ID: 25773578
[TBL] [Abstract][Full Text] [Related]
19. SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT(1A) receptor ligands using CORAL.
Veselinović AM; Milosavljević JB; Toropov AA; Nikolić GM
Eur J Pharm Sci; 2013 Feb; 48(3):532-41. PubMed ID: 23287365
[TBL] [Abstract][Full Text] [Related]
20. New dual 5-HT1A and 5-HT7 receptor ligands derived from SYA16263.
Ofori E; Onyameh EK; Gonela UM; Voshavar C; Bricker B; Swanson TL; Eshleman AJ; Schmachtenberg JL; Bloom SH; Janowsky AJ; Ablordeppey SY
Eur J Med Chem; 2021 Mar; 214():113243. PubMed ID: 33582388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]